BUPHENYL

Horizon Therapeutics USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 11, 2023
Approval ID: 463a36fa-3eb2-4326-8bd0-c8c7a11bca3a
Products: 2 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

BUPHENYL (sodium phenylbutyrate) Tablets BUPHENYL (sodium phenylbutyrate) Powder

Quick Stats

Total Products2

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.